Loading…
Yuanta Securities maintained its Buy rating and 260,000-won target price for CJ CheilJedang, saying a sustained share-price recovery depends on a recovery in biotech product prices and improved food-business profitability. The company’s third-quarter revenue excluding CJ Logistics rose 5.7% year over year to 4.23 trillion won, while operating profit increased 6.9% to 203 billion won; Yuanta forecasts fourth-quarter operating profit of 212 billion won.
A recovery in prices for the company's biotech products could improve its earnings, but the report does not specify feed-ingredient prices or a clear supply-demand change. Feed-market implications are therefore limited.
en.edaily.co.krKwon Oh SeokNov 10, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
